Aniridia‐associated keratopathy: Clinical and molecular mechanisms of disease progression and emerging therapeutic targets

Congenital aniridia is a rare genetic disorder primarily caused by pathogenic variants of the PAX6 gene. It leads to various panocular anomalies, including aniridia-associated keratopathy (AAK). This review highlights recent insights into its pathogenesis, focusing on clinical staging, microstructural changes in the cornea and molecular dysregulation. We synthesized clinical and experimental findings from large European cohorts, integrating data on over 550 eyes. AAK severity correlates with iris malformation, secondary glaucoma and lens status. In vivo confocal microscopy reveals a reduction in subbasal nerve plexus density, altered keratocyte and endothelial morphology and an increase in Langerhans cell infiltration. RNA and miRNA microarrays, as well as RNA-seq studies, highlight dysregulated miRNAs (such as miR-204-5p and miR-138-5p) and altered expression of PAX6 and keratocyte markers. Limbal fibroblasts show enhanced inflammatory responses and vulnerability to oxidative stress. Advanced AAK is associated with a reduced quality of life. The progression of AAK involves intricate interactions between developmental deficits, inflammation and changes in the limbal microenvironment, suggesting molecular targets for future therapies.

Authors

Institutions

Publication Details

Journal
Acta Ophthalmologica
Published
2026-02-03
DOI
https://doi.org/10.1111/aos.70086
Citations
1
Primary Topic
Developmental Biology and Gene Regulation
Type
article
Field-Weighted Citation Impact
22.24

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Aniridia‐associated keratopathy: Clinical and molecular mechanisms of disease progression and emerging therapeutic targets

Gábor Tóth, Anita Csorba, Annamária Náray, L. Latta et al.
1 citations
Acta Ophthalmologica
Developmental Biology and Gene Regulation
22.24
article

Aniridia‐associated keratopathy: Clinical and molecular mechanisms of disease progression and emerging therapeutic targets

Gábor Tóth, Anita Csorba, Annamária Náray, L. Latta, Oliver Stachs, Shweta Suiwal, Juana Gallar, Nóra Szentmáry, Mária Csidey, Zamira Hoxha, Simon Trusen, M. Amini, K. Tory, B. Käsmann‐Kellner, A. Langenbucher, F. N. Fries, Z. Z. Nagy, S. Li, E. Maka, T. Stachon, J. Zimmermann, S. Kundu, M. C. Acosta, Z. Li, S. Liu, B. Seitz, S. L. Hsu, M. Cortón‐Perez
article en
1 citations

Abstract

Congenital aniridia is a rare genetic disorder primarily caused by pathogenic variants of the PAX6 gene. It leads to various panocular anomalies, including aniridia-associated keratopathy (AAK). This review highlights recent insights into its pathogenesis, focusing on clinical staging, microstructural changes in the cornea and molecular dysregulation. We synthesized clinical and experimental findings from large European cohorts, integrating data on over 550 eyes. AAK severity correlates with iris malformation, secondary glaucoma and lens status. In vivo confocal microscopy reveals a reduction in subbasal nerve plexus density, altered keratocyte and endothelial morphology and an increase in Langerhans cell infiltration. RNA and miRNA microarrays, as well as RNA-seq studies, highlight dysregulated miRNAs (such as miR-204-5p and miR-138-5p) and altered expression of PAX6 and keratocyte markers. Limbal fibroblasts show enhanced inflammatory responses and vulnerability to oxidative stress. Advanced AAK is associated with a reduced quality of life. The progression of AAK involves intricate interactions between developmental deficits, inflammation and changes in the limbal microenvironment, suggesting molecular targets for future therapies.

Acta Ophthalmologica
Semmelweis University (HU), Instituto de Salud Carlos III (ES), Heim Pál Országos Gyermekgyógyászati Intézet (HU), Centre for Biomedical Network Research on Rare Diseases (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) (ES), University of Rostock (DE), Universidad Autónoma de Madrid (ES), Saarland University (DE)
Deutsche Forschungsgemeinschaft, China Scholarship Council, Universität des Saarlandes, Deutsche Ophthalmologische Gesellschaft, Dr. Rolf M. Schwiete Stiftung
Openalex Percentile: Top 1%
Developmental Biology and Gene Regulation
22.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.